Analysis of Antioxidant as a Therapeutic Agent for Atherosclerosis

E-ISSN： 1875-676x|2|4|369-384

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.2, Iss.4, 2006-11, pp. : 369-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PolySOD-catalase as a therapeutic agent with antioxidant properties

By Gu Jingsong Wang Yuanxiu

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 47, Iss. 7, 2009-07 ,pp. : 620-623

Informa Healthcare

Access to resources Recommend Favorite

Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis

Current Medicinal Chemistry, Vol. 24, Iss. 12, 2017-06 ,pp. : 1214-1227

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Potential Therapeutic Targets in Atherosclerosis

Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. : 13-27

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targeting of P-Selectin in Atherosclerosis

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 1, 2007-03 ,pp. : 69-74

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: A New Therapeutic Target

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite